New Treatment Strategy for Patients With Multiple Recurrent Clostridioides Difficile Infection With Bezlotoxumab as First Option
Latest Information Update: 30 Mar 2023
At a glance
- Drugs Bezlotoxumab (Primary) ; Vancomycin
- Indications Clostridium difficile infections; Diarrhoea
- Focus Therapeutic Use
- Acronyms BSTEP
- 24 Mar 2023 Status changed from discontinued to withdrawn prior to enrolment.
- 15 Oct 2021 New trial record